401
Dr. Sulaiman
Stock
Stock
ISIN: SA1510P1UMH1
Ticker: 4013
SA1510P1UMH1
4013
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 04.03.2025
$0.93
CHART BY
Frequently asked questions
What is Dr. Sulaiman's market capitalization?
The market capitalization of Dr. Sulaiman is $27.26B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Dr. Sulaiman's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Dr. Sulaiman is 45.93. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Dr. Sulaiman?
Dr. Sulaiman's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.696. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Dr. Sulaiman's stock?
Currently, 9 analysts cover Dr. Sulaiman's stock, with a consensus target price of $82.94. Analyst ratings provide insights into the stock's expected performance.
What is Dr. Sulaiman's revenue over the trailing twelve months?
Over the trailing twelve months, Dr. Sulaiman reported a revenue of $2.81B.
What is the EBITDA for Dr. Sulaiman?
Dr. Sulaiman's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $701.73M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Dr. Sulaiman?
Dr. Sulaiman has a free cash flow of -$187.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Dr. Sulaiman's shares?
The free float of Dr. Sulaiman is 102.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $27.26B
- EPS (TTM)
- $1.696
- Free Float
- 102.19M
- P/E ratio (TTM)
- 45.93
- Revenue (TTM)
- $2.81B
- EBITDA (TTM)
- $701.73M
- Free Cashflow (TTM)
- -$187.54M
Pricing
- 52W span
- $68.73$92.47
Analyst Ratings
The price target is $82.94 and the stock is covered by 9 analysts.
Buy
4
Hold
4
Sell
1
Information
Dr. Sulaiman Al-Habib Medical Group owns and operates a number of hospitals and medical centers. It operates through the following segments: Hospitals, Pharmacies, and HMG Solutions. The company was founded by Sulaiman Abdulaziz Al-Habib in 1995 and is headquartered in Riyadh, Saudi Arabia.
- Industries
- Hospital/ Nursing Management
- Sector
- Health Care
Identifier
- ISIN
- SA1510P1UMH1
- Primary Ticker
- 4013